Bellevue Group Ag Care Dx, Inc. Transaction History

Bellevue Group Ag

$4.31 Billion
Q1 2025

A detailed history of Bellevue Group Ag transactions in Care Dx, Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 889,003 shares of CDNA stock, worth $16.8 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

889,003

Previous 1,374,412 35.32%

Holding current value

$16.8 Million

Previous $29.4 Million 46.38%

% of portfolio

0.37%

Previous 0.59%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$17.64 - $25.07 $8.56 Million - $12.2 Million	-485,409 Reduced 35.32%	889,003 $15.8 Million
Q4 2024 Feb 14, 2025	SELL	$20.4 - $32.2 $36.1 Million - $57 Million	-1,771,044 Reduced 56.3%	1,374,412 $29.4 Million
Q3 2024 Nov 14, 2024	SELL	$14.41 - $33.99 $11.1 Million - $26.1 Million	-767,119 Reduced 19.61%	3,145,456 $98.2 Million
Q2 2024 Aug 14, 2024	SELL	$7.56 - $16.15 $162,018 - $346,110	-21,431 Reduced 0.54%	3,912,575 $60.8 Million
Q1 2024 May 15, 2024	SELL	$7.96 - $12.37 $165,456 - $257,122	-20,786 Reduced 0.53%	3,934,006 $41.7 Million
Q4 2023 Feb 14, 2024	BUY	$4.9 - $12.86 $68,570 - $179,962	13,994 Added 0.36%	3,954,792 $47.5 Million
Q3 2023 Nov 14, 2023	BUY	$7.0 - $11.26 $1.57 Million - $2.53 Million	224,321 Added 6.04%	3,940,798 $27.6 Million
Q2 2023 Aug 14, 2023	BUY	$7.61 - $9.46 $2.11 Million - $2.62 Million	277,386 Added 8.07%	3,716,477 $31.6 Million
Q1 2023 May 15, 2023	BUY	$8.83 - $17.61 $2.39 Million - $4.77 Million	270,643 Added 8.54%	3,439,091 $31.4 Million
Q4 2022 Feb 14, 2023	BUY	$10.88 - $20.05 $6.17 Million - $11.4 Million	567,002 Added 21.8%	3,168,448 $36.2 Million
Q3 2022 Nov 14, 2022	BUY	$16.06 - $26.39 $1.03 Million - $1.69 Million	63,922 Added 2.52%	2,601,446 $44.3 Million
Q2 2022 Aug 11, 2022	BUY	$20.49 - $39.72 $4.64 Million - $8.99 Million	226,348 Added 9.79%	2,537,524 $54.5 Million
Q1 2022 May 13, 2022	BUY	$28.19 - $46.6 $23.8 Million - $39.4 Million	844,624 Added 57.59%	2,311,176 $85.5 Million
Q4 2021 Feb 10, 2022	BUY	$41.2 - $73.6 $59.1 Million - $106 Million	1,435,609 Added 4639.53%	1,466,552 $66.7 Million
Q3 2021 Nov 12, 2021	SELL	$59.15 - $91.99 $6.98 Million - $10.8 Million	-117,928 Reduced 79.21%	30,943 $1.96 Million
Q2 2021 Aug 12, 2021	SELL	$63.02 - $95.11 $2.62 Million - $3.95 Million	-41,500 Reduced 21.8%	148,871 $13.6 Million
Q1 2021 May 12, 2021	SELL	$57.62 - $95.6 $8.85 Million - $14.7 Million	-153,612 Reduced 44.66%	190,371 $13 Million
Q4 2020 Feb 16, 2021	SELL	$41.43 - $77.09 $32 Million - $59.5 Million	-771,920 Reduced 69.17%	343,983 $24.9 Million
Q3 2020 Nov 16, 2020	SELL	$30.88 - $37.94 $1.57 Million - $1.93 Million	-50,936 Reduced 4.37%	1,115,903 $42.3 Million
Q2 2020 Aug 13, 2020	SELL	$18.95 - $35.43 $2.09 Million - $3.9 Million	-110,212 Reduced 8.63%	1,166,839 $41.3 Million
Q1 2020 May 14, 2020	BUY	$13.94 - $28.25 $1.4 Million - $2.83 Million	100,321 Added 8.53%	1,277,051 $27.9 Million
Q4 2019 Feb 14, 2020	BUY	$19.24 - $28.41 $8.74 Million - $12.9 Million	454,075 Added 62.83%	1,176,730 $25.4 Million
Q3 2019 Nov 14, 2019	BUY	$20.03 - $40.08 $4.62 Million - $9.24 Million	230,647 Added 46.88%	722,655 $16.3 Million
Q2 2019 Aug 14, 2019	BUY	$25.78 - $39.77 $1.56 Million - $2.4 Million	60,440 Added 14.0%	492,008 $17.7 Million
Q1 2019 May 15, 2019	SELL	$22.09 - $39.21 $2.32 Million - $4.11 Million	-104,920 Reduced 19.56%	431,568 $13.6 Million
Q4 2018 Feb 12, 2019	SELL	$19.89 - $30.02 $6.7 Million - $10.1 Million	-337,049 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$12.1 - $28.85 $4.08 Million - $9.72 Million	337,049 New	337,049 $9.72 Million

Others Institutions Holding CDNA

# of Institutions

230

Shares Held

56.9M

Call Options Held

51.2K

Put Options Held

46K

View Full List

About CareDx, Inc.

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.01B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

More about CDNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account

Bellevue Group Ag Care Dx, Inc. Transaction History